Trials / Completed
CompletedNCT00417157
Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH
Successful Application of Modified Natural Cycle in Poor Responders With High Basal FSH Prior to Oocyte Donation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 135 (actual)
- Sponsor
- Eugonia · Academic / Other
- Sex
- Female
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effectiveness of a modified natural cycle in patients with previous poor response to infertility drugs and high basal FSH, prior to proceeding to oocyte donation or abandoning fertility treatment.
Detailed description
Poor responders are a diverse group of IVF patients who fail to respond to IVF drugs. In these patients pregnancy rates remain disappointingly low and usually oocyte donation is their only viable option. The need for lengthy ovarian stimulation regimes can be avoided by performing IVF during a natural menstrual cycle. However, the main problem with a natural cycle is that successful IVF outcome can be compromised by a premature LH surge. This problem can be solved by the administration of GnRH antagonists that suppress endogenous gonadotropin levels, comprising a modified natural cycle (MNC). Previous studies have shown that MNC offers no realistic chances of pregnancy prior to oocyte donation. In this study we will re-assess this view by showing that MNC offers some, albeit small, chances of positive IVF outcome in patients with known previous poor response prior to oocyte donation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | recombinant FSH (Puregon, Organon, The Netherlands) | |
| DRUG | GnRH antag: Ganirelix (Orgalutran, Organon, The Netherlands) | |
| DRUG | hCG (Pregnyl, Organon, The Netherlands) |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2006-12-29
- Last updated
- 2013-12-16
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT00417157. Inclusion in this directory is not an endorsement.